About

3Aware.ai focuses on post-market surveillance (PMS) for medical devices, helping manufacturers comply with regulations like the EU Medical Device Regulation (MDR). Their main product, aiSurveillance, is a real-time software platform that combines three separate solutions into one, allowing for efficient access, analysis, and alerts regarding real-world clinical data. By using artificial intelligence, the platform automates data collection and analysis, which helps clinical and regulatory teams save time and reduce costs. Unlike competitors, 3Aware.ai offers a customizable solution tailored to the specific needs of each client, ensuring ongoing support and updates through a subscription-based model. The goal of 3Aware.ai is to enhance the safety and effectiveness of medical devices while streamlining compliance processes for manufacturers.

Simplify's Take

What believers are saying

• The integration with Mayo Clinic enhances device coverage and automates post-market clinical follow-up.
• 3Aware's aiSurveillance reduces compliance costs by 50% and time by 90%.
• The appointment of Prashant Thumma as CTO strengthens 3Aware's technology leadership.

What critics are saying

• Over-reliance on Mayo Clinic data may limit diversity and increase vulnerability.
• New CTO Prashant Thumma's strategies might disrupt current operations or delay projects.
• Raising $8 million in equity suggests potential cash flow challenges for 3Aware.

What makes 3Aware unique

• 3Aware.ai integrates three solutions into one platform, enhancing efficiency in post-market surveillance.
• The aiSurveillance platform automates data collection, reducing time and costs for MedTech companies.
• 3Aware's collaboration with Mayo Clinic provides access to extensive, diverse clinical data.

Help us improve and share your feedback! Did you find this helpful?

YesNo